Platelet reactivity influences clot structure as assessed by fractal analysis of viscoelastic properties

References

• Dahlback B. Blood coagulation. Lancet 2000;355:1627–1632.
   Google Scholar
• Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482–2494.
   PubMed Web of Science ®Google Scholar
• Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006;99:1293–1304.
   PubMed Web of Science ®Google Scholar
• Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002;88:186–193.
   PubMed Web of Science ®Google Scholar
• Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22:1381–1389.
   PubMed Web of Science ®Google Scholar
• Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004;104:1606–1615.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Clopidogrel in unstable angina to prevent recurrent events Trial I. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494–502.
   Google Scholar
• Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ, Observation CICftRoED. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411–2420.
   Google Scholar
• Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003;110:255–258.
   PubMed Web of Science ®Google Scholar
• Hechler B, Cattaneo M, Gachet C. The P2 receptors in platelet function. Semin Thromb Hemost 2005;31:150–161.
   PubMed Web of Science ®Google Scholar
• Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, Kirtane A, Siller-Matula J, Mahla E, Becker RC, Bhatt DL, Waksman R, Rao SV, Alexopoulos D, Marcucci R, Reny JL, Trenk D, Sibbing D, Gurbel PA. consensus and update on the definition of on-treatment platelet reactivity to ADP associated with ischemia and bleeding. J Am Coll Cardiol 2013;62(24).
   Google Scholar
• Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK. Platelet physiology subcommittee of the S, standardization committee of the international society on T, haemostasis, working group on aspirin R. Aspirin resistance: position paper of the working group on aspirin resistance. J Thrombosis Haemostasis 2005;3:1309–1311.
   Google Scholar
• Price MJ, Angiolillo DJ, Teirstein PS, Lillie E, Manoukian SV, Berger PB, Tanguay JF, Cannon CP, Topol EJ. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial. Circulation 2011;124:1132–1137.
   PubMed Web of Science ®Google Scholar
• Collet JP, Cuisset T, Range G, Cayla G, Elhadad S, Pouillot C, Henry P, Motreff P, Carrie D, Boueri Z, Belle L, Van Belle E, Rousseau H, Aubry P, Monsegu J, Sabouret P, O’Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Barthelemy O, Beygui F, Silvain J, Vicaut E, Montalescot G, Investigators A. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 2012;367:2100–2109.
   PubMed Web of Science ®Google Scholar
• Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 2000;20:1354–1361.
   PubMed Web of Science ®Google Scholar
• Scott EM, Ariens RA, Grant PJ. Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004;24:1558–1566.
   PubMed Web of Science ®Google Scholar
• Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem 1992;267:24259–24263.
   PubMed Web of Science ®Google Scholar
• Collet JP, Lesty C, Montalescot G, Weisel JW. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. J Biol Chem 2003;278:21331–21335.
   PubMed Web of Science ®Google Scholar
• Colle JP, Mishal Z, Lesty C, Mirshahi M, Peyne J, Baumelou A, Bensman A, Soria J, Soria C. Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost 1999;82:1482–1489.
   PubMed Web of Science ®Google Scholar
• Fatah K, Silveira A, Tornvall P, Karpe F, Blomback M, Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 1996;76:535–540.
   PubMed Web of Science ®Google Scholar
• Greilich PE, Carr ME, Zekert SL, Dent RM. Quantitative assessment of platelet function and clot structure in patients with severe coronary artery disease. Am J Med Sci 1994;307:15–20.
   PubMed Web of Science ®Google Scholar
• Nair CH, Azhar A, Wilson JD, Dhall DP. Studies on fibrin network structure in human plasma. Part II–Clinical application: diabetes and antidiabetic drugs. Thromb Res 1991;64:477–485.
   Google Scholar
• Undas A, Zawilska K, Ciesla-Dul M, Lehmann-Kopydlowska A, Skubiszak A, Ciepluch K, Tracz W. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood 2009;114:4272–4278.
   PubMed Web of Science ®Google Scholar
• Ariens RA. Denser matters. Blood 2009;114:3978–3979.
   PubMed Web of Science ®Google Scholar
• Weisel JW. The mechanical properties of fibrin for basic scientists and clinicians. Biophys Chem 2004;112:267–276.
   PubMed Web of Science ®Google Scholar
• Evans PA, Hawkins K, Morris RH, Thirumalai N, Munro R, Wakeman L, Lawrence MJ, Williams PR. Gel point and fractal structure of incipient blood clots are significant new markers of hemostasis for healthy and anticoagulated blood. Blood 2010;116:3341–3346.
   Google Scholar
• Losa GA. The fractal geometry of life. Riv Biol 2009;102:29–59.
   Google Scholar
• Stanford SN, Sabra A, D’Silva L, Lawrence MJ, Morris RHK, Storton S, Brown MR, Evans V, Hawkins K, Williams PR, Davidson SJ, Wani M, Potter JF, Evans PA. The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study. BMC Neurol 2014;15:35.
   Web of Science ®Google Scholar
• Lawrence MJ, Sabra A, Thomas P, Obaid DR, D’Silva LA, Morris RH, Hawkins K, Brown MR, Williams PR, Davidson SJ, Chase AJ, Smith D, Evans PA. Fractal dimension: a novel clot structure biomarker use in ST elevation myocardial infarction patients. Atherosclerosis 2015;240:402–407.
   Google Scholar
• Lawrence MJ, Sabra A, Mills G, Pillai SG, Abdullah W, Hawkins K, Morris RH, Davidson SJ, D’Silva LA, Curtis DJ, Brown MR, Weisel JW, Williams PR, Evans PA. A new biomarker quantifies differences in clot structure in patients with venous thromboembolism. Br J Haematol 2015;168:571–575.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Kumar S, Hawkins K, Boden S, Rutt H, Mills G, Sabra A, Morris RH, Davidson SJ, Badiei N, Brown MR, Williams PR, Evans PA. A new structural biomarker that quantifies and predicts changes in clot strength and quality in a model of progressive haemodilution. Thromb Res 2014;134:488–494.
   PubMed Web of Science ®Google Scholar
• Davies NA, Harrison NK, Morris RH, Noble S, Lawrence MJ, D’Silva LA, Broome L, Brown MR, Hawkins KM, Williams PR, Davidson S, Evans PA. Fractal dimension (df) as a new structural biomarker of clot structure in different stages of lung cancer. Thromb Haemost 2015;114:1251–1259.
   Google Scholar
• Badiei N, Sowedan AM, Curtis DJ, Brown MR, Lawrence MJ, Campbell AI, Sabra A, Evans PA, Weisel JW, Chernysh IN, Nagaswami C, Williams PR, Hawkins K. Effects of unidirectional flow shear stresses on the formation, fractal structure and rigidity of incipient whole blood clots and fibrin gels. Clin Hemorheol Microcirc 2015;60:451–464.
   PubMed Web of Science ®Google Scholar
• Ferri F, Greco M, Arcovito G, De Spirito M, Rocco M. Structure of fibrin gels studied by elastic light scattering techniques: dependence of fractal dimension, gel crossover length, fiber diameter, and fiber density on monomer concentration. Phys Rev E Stat Nonlin Soft Matter Phys 2002;66:011913.
   PubMed Web of Science ®Google Scholar
• Langer BG, Weisel JW, Dinauer PA, Nagaswami C, Bell WR. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem 1988;263:15056–15063.
   PubMed Web of Science ®Google Scholar
• Lordkipanidze M, Lowe GC, Kirkby NS, Chan MV, Lundberg MH, Morgan NV, Bem D, Nisar SP, Leo VC, Jones ML, Mundell SJ, Daly ME, Mumford AD, Warner TD, Watson SP, Genotyping UK. Phenotyping of Platelets Study G. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay. Blood 2014;123:e11–22.
   Google Scholar
• Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP, Lussana F, Pugliano MT, Michelson AD. Recommendations for the standardization of light transmission aggregometry: A consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost 2013;11(6):1183–1189.
   Google Scholar
• Leon C, Alex M, Klocke A, Morgenstern E, Moosbauer C, Eckly A, Spannagl M, Gachet C, Engelmann B. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 2004;103:594–600.
   PubMed Web of Science ®Google Scholar
• Bjornsson TD, Schneider DE, Berger H Jr. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharmacol Exp Ther 1989;250:154–161.
   Google Scholar
• He S, Blomback M, Yoo G, Sinha R, Henschen-Edman AH. Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system. Ann N Y Acad Sci 2001;936:531–535.
   PubMed Web of Science ®Google Scholar
• Bjorkman JA, Zachrisson H, Forsberg GB, Von Bahr H, Hansson GI, Warner TD, Nylander S. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition. Thromb Res 2013;131:313–319.
   PubMed Web of Science ®Google Scholar
• Warner TD, Armstrong PC, Curzen NP, Mitchell JA. Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists? Heart 2010;96:1693–1694.
   PubMed Web of Science ®Google Scholar
• Zwaal RF, Comfurius P, Bevers EM. Lipid-protein interactions in blood coagulation. Biochim Biophys Acta 1998;1376:433–453.
   PubMed Web of Science ®Google Scholar
• Gailani D, Ho D, Sun MF, Cheng Q, Walsh PN. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential. Blood 2001;97:3117–3122.
   PubMed Web of Science ®Google Scholar
• Monkovic DD, Tracy PB. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 1990;265:17132–17140.
   PubMed Web of Science ®Google Scholar
• Muller I, Klocke A, Alex M, Kotzsch M, Luther T, Morgenstern E, Zieseniss S, Zahler S, Preissner K, Engelmann B. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J Off Publ Fed Am Soc Exp Biol 2003;17:476–478.
   PubMed Web of Science ®Google Scholar
• Roberts HR, Monroe DM, Oliver JA, Chang JY, Hoffman M. Newer concepts of blood coagulation. Haemophilia Off J World Fed Hemophilia 1998;4:331–334.
   PubMed Web of Science ®Google Scholar
• Braaten JV, Jerome WG, Hantgan RR. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface. Blood 1994;83:982–993.
   PubMed Web of Science ®Google Scholar
• Collet J, Montalescot G, Lesty C, Weisel JW, Structural A. Dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circ Res 2002;90:428–434.
   PubMed Web of Science ®Google Scholar
• Neergaard-Petersen S, Ajjan R, Hvas AM, Hess K, Larsen SB, Kristensen SD, Grove EL. Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure. PLoS One 2013;8:e71150.
   PubMed Web of Science ®Google Scholar